Results 21 to 30 of about 72,675 (217)

Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages

open access: yesJournal of Lipid Research, 2005
The mobilization of cholesterol from intracellular pools to the plasma membrane is a determinant that governs its availability for efflux to extracellular acceptors.
G. Chinetti-Gbaguidi   +9 more
doaj   +1 more source

Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV

open access: yesPharmaceutical Biology, 2017
Context: The available treatments for the abnormal proliferation of vascular smooth muscle cells (VSMCs) are still dismal. Berberine has been demonstrated to possess extensive medicine activity, yet relatively little is known about its effect on VSMCs ...
Hongmei Qiu   +7 more
doaj   +1 more source

Peroxisome Proliferator-Activated Receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes

open access: yesRespiratory Research, 2006
Background PPARs exhibit anti-inflammatory capacities and are potential modulators of the inflammatory response. We hypothesized that their expression and/or function may be altered in cystic fibrosis (CF), a disorder characterized by an excessive host ...
Wagner Thomas   +5 more
doaj   +1 more source

Role of metabolic nuclear receptors in acute liver injury and drug-induced hepatotoxicity

open access: yesPharmacological Research
Metabolic nuclear receptors (NRs) are ligand-activated transcription factors central to metabolic homeostasis and detoxification. While their roles in chronic liver diseases have been reviewed, comprehensive reviews specifically addressing the role of ...
Liangliang Nie   +4 more
doaj   +1 more source

Peroxisome proliferator-activated receptor α polymorphisms and postprandial lipemia in healthy men

open access: yesJournal of Lipid Research, 2007
Peroxisome proliferator-activated receptor α (PPARα) is a ligand-dependent transcription factor that plays a key role in lipid and glucose homeostasis. This study evaluated whether variants of PPARα are associated with postprandial lipemia. Subjects were
Toshiko Tanaka   +7 more
doaj   +1 more source

Identifying transcription factors controlling the basal expression of human MRP4 highlights a substantial role for Sp1

open access: yesFEBS Open Bio, EarlyView.
The MRP4 transporter exports several drugs and signaling molecules. Here, we identified key promoter elements regulating basal MRP4 expression. Using reporter assays, we defined a conserved region with essential Sp1 and contributory Ets sites, which controlled basal MRP4 expression.
Debora Singer   +7 more
wiley   +1 more source

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Morphological and biochemical maladaptation of cardiomyocytes are associated with mitochondrial dysfunction and dysregulation in hypertrophic conditions.
Dipak Kar, Arun  Bandyopadhyay
doaj   +1 more source

Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. [PDF]

open access: yesPLoS ONE, 2014
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic triglyceride accumulation, ranging from steatosis to steatohepatitis and cirrhosis.
Fang Yan   +10 more
doaj   +1 more source

Additional file 1: of Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population

open access: yes, 2018
Table S1. Top 10 SNPs associated with plasma MDA. Figure S1. Flow of the study participants. (DOCX 112 kb)
Kim, Minjoo   +4 more
openaire   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

open access: yesFEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy